Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash DealLOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not ...
C21 Investments Repays $30 Million Debt to CEO Sonny NewmanLOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion ...
News Team2023-06-02T13:57:25-08:00Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
News Team2023-06-02T07:40:03-08:00Trulieve Disciplined for Worker Death; Announces Exit from Competitive California & Massachusetts Markets
News Team2023-06-01T10:07:54-08:00Minnesota Legalizes Recreational Cannabis, Expanding Market and Tax Revenue
News Team2023-06-02T07:46:03-08:00California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
News Team2023-06-01T19:08:23-08:00Humble & Fume Inc. Announces Intention to Raise Approximately C$2 Million through Non-Brokered Private Placement
News Team2023-05-31T16:13:22-08:00Innocan Pharma Reports Significant Revenue Growth & Gross Profit in Q1 2023
News Team2023-05-02T13:19:20-08:00California’s Garden Society Announces Two-Fold Partnership with Kiva Confections and Kiva Sales and Service
News Team2023-04-21T13:41:07-08:00High Tide and [Re] Waste Team Up to Celebrate Earth Day: A Revolutionary Initiative for Sustainable Cannabis Packaging
News Team2023-04-18T13:01:17-08:00Curaleaf Granted Approval to Continue Selling Recreational Cannabis in New Jersey After Initial Denial
News Team2023-06-01T10:07:54-08:00Minnesota Legalizes Recreational Cannabis, Expanding Market and Tax Revenue
News Team2023-05-26T07:23:33-08:00Uncertain Future for Medical Cannabis Expansion in Texas as Legislative Session Nears Conclusion
News Team2023-05-25T08:32:23-08:00Minnesota Legislature Advances Health Policy Bill with Psychedelics Task Force Provision
News Team2023-05-29T20:02:24-08:00Massachusetts Regulators Scrap Pilot Program for Cannabis Consumption Cafes, Prioritize Broader Approach
News Team2023-05-26T07:18:20-08:00California’s Legal Cannabis Market Faces Declining Sales in Q1 2023
News Team2023-05-25T08:17:23-08:00Clearmind Medicine Initiates Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder at Yale School of Medicine
News Team2023-05-25T08:04:36-08:00PharmaDrug Appoints David Posner as Advisor to Enhance Shareholder Value and Explores Strategic Options for Cepharanthine and DMT Programs
News Team2023-05-31T18:20:57-08:00Opinion: Cannabis PR Scares Me…and It Should Scare You Too–By Lauren Mundell
News Team2023-04-16T17:51:26-08:00Trump Claims ”Genetically Engineered” Cannabis Causes Mass Shootings
News Team2023-05-24T18:00:06-08:00Legacy Cannabis Growers Raise Concerns as Eswatini Considers Legalization
News Team2023-04-17T07:34:13-08:00Germany Shifts Plan for Cannabis Legalization to Nonprofits and Personal Use
News Team2023-04-12T19:54:29-08:00Germany Legalizes Adult-Use Cannabis via Cannabis Clubs & Home Grow Cultivation
News Team2023-03-17T17:57:53-08:00Australian Nurses Call for Medicinal Cannabis Education in Undergraduate Degrees
News Team2022-05-31T10:52:41-08:00A Psychedelics Deep Dive: Capital Flow in the Psychedelics Industry: Part 4 of 4
News Team2022-05-31T10:49:47-08:00Psychedelics Deep Dive: Psychedelic Medicines in Development: Part 3 of 4
News Team2022-05-31T10:53:55-08:00Psychedelics Deep Dive: Key Players in the Psychedelics Industry: Part 2 of 4